Stocks MAAS Financial statements
Financial statementsMaase Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data Maase Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|---|
| Revenue | 29.9 | 28.2 | 15.8 | 163 | 109 | 27 |
| Cost of revenue | 5.05 | 2.23 | 23.3 | |||
| Gross profit | 23.1 | 13.6 | 3.71 | |||
| Research and development | 0.67 | |||||
| Selling and marketing | 17.6 | |||||
| General and administrative | 15.3 | 12.7 | 51.8 | 77.7 | 6.01 | |
| Operating expenses | -40.9 | |||||
| Operating income | -11.3 | -11.1 | -8.11 | -63.4 | -96.5 | -3.49 |
| Interest expense | 0.21 | |||||
| Interest income | 0.29 | 1.87 | 2.29 | 3.95 | ||
| Other non-operating income | 0.73 | 0.75 | 0.23 | -5.12 | -82.6 | 0.15 |
| Pre-tax income | -8.62 | -9.2 | -4.83 | -68.5 | -49.2 | -1.66 |
| Income tax | -1.49 | -0.14 | 1.18 | 1.78 | -2.74 | -0.06 |
| Income from continuing operations | -7.14 | -22.9 | -3.2 | |||
| Net income to minority interests | -30.6 | -247 | ||||
| Net income | -6.46 | -9.06 | -6.01 | -39.9 | -27.4 | -27.6 |
| EBITDA | -10.8 | -10.2 | -7.62 | -62.3 | ||
| EPS, basic | -0.08 | -0.10 | -0.07 | -0.17 | -3.63 | -0.10 |
| EPS, diluted | -0.08 | -0.10 | -0.07 | -0.17 | -3.61 | -0.17 |
| Shares, basic (weighted) | 90.5 | 90.5 | 1.01 | 2.59 | 7.61 | 295 |
| Shares, diluted (weighted) | 90.5 | 90.5 | 1.01 | 2.59 | 7.61 | 295 |
Balance sheet
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|---|
| Cash and equivalents | 40.4 | 29 | 164 | 40.7 | 11.5 | 5.47 |
| Short-term investments | 0.75 | 80.4 | 76.5 | 5.43 | ||
| Receivables | 8.54 | 8.88 | 5.19 | 37.6 | 13 | 4.44 |
| Inventory | 355 | |||||
| Other current assets | 3.82 | 6.71 | 3.34 | 4 | ||
| Total current assets | 62.5 | 58.9 | 32.8 | 328 | 307 | 393 |
| Property, plant and equipment | 1.55 | 1.37 | 0.22 | 11.9 | 9.85 | 2.52 |
| Lease right-of-use assets | 4.85 | 16.8 | 8.65 | 0.41 | ||
| Goodwill | 33.5 | 297 | ||||
| Intangible assets | 0.25 | 0.17 | 0.25 | 57.5 | 0.12 | 17 |
| Long-term investments | 0.75 | |||||
| Other non-current assets | 31 | 54.8 | 0.11 | |||
| Total assets | 72.5 | 69.3 | 37.4 | 589 | 470 | 726 |
| Accounts payable | 1.91 | 1.74 | 0.87 | 26.7 | 16.3 | 3.57 |
| Accrued liabilities | 20.4 | 13.9 | ||||
| Deferred revenue | 4.16 | |||||
| Short-term debt | 13.5 | 11.5 | 0.95 | |||
| Total current liabilities | 20.2 | 25 | 4.28 | 117 | 80.1 | 36.8 |
| Long-term debt | 0.3 | |||||
| Lease liabilities | 8.66 | 4.18 | 0.22 | |||
| Other non-current liabilities | 4.59 | |||||
| Total liabilities | 22.9 | 30.4 | 7.52 | 225 | 164 | 38.4 |
| Total debt | 1.25 | |||||
| Paid-in capital | 34.8 | 33.5 | 31 | 218 | 157 | 859 |
| Retained earnings | 11.3 | 1.77 | -4.35 | -44.2 | -72.2 | -223 |
| Treasury stock | -0 | -0 | -0 | |||
| Other comprehensive income | -0.13 | -0.06 | 0.02 | -0.32 | -0.84 | 2.21 |
| Shareholders' equity | 49.6 | 38.8 | 177 | 88.8 | 680 | |
| Minority interests | 180 | 210 | 0.12 | |||
| Total equity | 49.6 | 38.8 | 29.9 | 357 | 299 | 680 |
| Total liabilities and equity | 72.5 | 69.3 | 37.4 | 589 | 470 | 726 |
| Shares outstanding | 90.5 | 90.5 | 90.5 | 371 |
Cash flow statement
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|---|
| Net income | -7.14 | -9.06 | -6.01 | -70.5 | -64.1 | -274 |
| Depreciation and amortization | 0.49 | 0.84 | 0.49 | 1.15 | ||
| Stock-based compensation | 3.21 | 10.2 | 0.17 | |||
| Deferred income tax | -1.65 | -0.36 | 1.02 | 1.28 | -0.72 | -1.36 |
| Change in receivables | -2.76 | -0.65 | 3.02 | 9.27 | 39.9 | 10.6 |
| Change in inventory | 3.29 | |||||
| Change in payables | 0.51 | -0.09 | -0.74 | -8.48 | -23.1 | |
| Cash from operations | -0.44 | -1.43 | -25.4 | 7.95 | 9.98 | -15.2 |
| Capital expenditures | -1.31 | -0.71 | -0.12 | -0.59 | -0.77 | -0.49 |
| Purchases of investments | -0.75 | -240 | -28.1 | -2.9 | ||
| Sales and maturities of investments | 0.05 | 2.51 | ||||
| Cash from investing | 7.43 | -1.58 | -0.69 | 32.2 | -45.7 | -16 |
| Stock issued | 0.01 | 0.01 | ||||
| Share buybacks | -1.38 | |||||
| Cash from financing | -11.9 | -1.98 | 18.2 | |||
| Exchange rate effect | -0.2 | 0.06 | 0.08 | 0.12 | 0.66 | 3.89 |
| Net change in cash | 7 | -3.01 | -30.3 | 28.2 | -37.7 | |
| Free cash flow | -1.74 | -2.13 | -25.5 | 7.35 | 9.2 | -15.7 |
| Interest paid | 0.13 | 0.64 | 0.61 | |||
| Income taxes paid | 0.01 | 0 | 0 | 0.72 | 1.43 | 0 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 13.7% | Gross profit / revenue. |
| Operating margin | -12.9% | Operating income / revenue. |
| Pre-tax margin | -6.1% | Pre-tax income / revenue. |
| Net margin | -102.1% | Net income / revenue. |
| FCF margin | -58.2% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | -56.4% | Cash from operations / revenue. |
| Return on equity (ROE) | -7.2% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | -4.6% | Net income / average total assets. |
| Return on invested capital (ROIC) | -0.7% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 2.5% | Research and development expense / revenue. |
| Stock-based pay / revenue | 0.6% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 1.8% | Capital expenditures / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | -75.2% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 19.6% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | -2.0% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit CAGR, 3y | -35.1% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | -252.8% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow growth, 1y | -270.9% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Book value growth, 1y | 665.7% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 5y | 68.8% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | 54.5% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 168.6% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 58.5% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | 3,779.0% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 564.6% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 26.7% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 10.7x | Current assets / current liabilities. |
| Quick ratio | 0.42x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.30x | (Cash + short-term investments) / current liabilities. |
| Debt / equity | 0.00x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 0.2% | Total debt / total assets. |
| Liabilities / assets | 5.3% | Total liabilities / total assets. |
| Net debt | -$9.6M | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Interest coverage | -16.9x | Operating income / interest expense. |
| Working capital | $356.2M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 43.3% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $365.5M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.05x | Revenue / average total assets. |
| Fixed asset turnover | 4.37x | Revenue / average property, plant and equipment. |
| Inventory turnover | 0.07x | Cost of revenue / average inventory. |
| Days inventory | 5,559 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 3.11x | Revenue / average receivables. |
| Days sales outstanding | 117 days | 365 x average receivables / revenue. |
| Days payables | 155 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | 5,521 days | Days inventory + days sales outstanding - days payables. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | -$0.17 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| EPS, basic | -$0.10 | Net income per basic share, as reported (split-adjusted). |
| Revenue per share | $0.09 | Revenue / diluted weighted shares. |
| FCF per share | -$0.05 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | -$0.05 | Cash from operations / diluted weighted shares. |
| Book value per share | $2.30 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $1.24 | Tangible book value / shares outstanding. |
| Cash per share | $0.04 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $4.31B | Share price x shares outstanding. |
| Enterprise value | $4.30B | Market cap + total debt - cash - short-term investments. |
| P/S | 159x | Market cap / revenue. |
| P/B | 6.33x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 11.8x | Market cap / tangible book value, when positive. |
| EV/Sales | 159x | Enterprise value / revenue. |
| FCF yield | -0.4% | Free cash flow / market cap. |
| Earnings yield | -0.6% | Net income / market cap (the inverse of P/E). |
What was Maase Inc.'s revenue in fiscal 2026?
Maase Inc. reported revenue of $27.0M for fiscal 2026, 75.2% lower than the year before.
Was Maase Inc. profitable in fiscal 2026?
No. It reported a net loss of $27.6M.
How much free cash flow did Maase Inc. generate in fiscal 2026?
Cash from operations of $15.2M minus capital expenditures of $485.0K left free cash flow of -$15.7M.